549 related articles for article (PubMed ID: 16113779)
1. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
[TBL] [Abstract][Full Text] [Related]
2. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
DeSancho MT; Dorff T; Rand JH
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
[TBL] [Abstract][Full Text] [Related]
4. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
7. The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
Lo Faro V; Johansson T; Johansson Å
Am J Obstet Gynecol; 2024 Mar; 230(3):360.e1-360.e13. PubMed ID: 37734636
[TBL] [Abstract][Full Text] [Related]
8. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
[TBL] [Abstract][Full Text] [Related]
9. Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
Spannagl M; Heinemann LA; Schramm W
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):105-12. PubMed ID: 10943572
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based indications for thrombophilia screening.
Lindhoff-Last E; Luxembourg B
Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 czech women.
Dulícek P; Malý J; Pecka M; Beránek M; Cermáková E; Malý R
Clin Appl Thromb Hemost; 2009 Oct; 15(5):567-73. PubMed ID: 19117968
[TBL] [Abstract][Full Text] [Related]
14. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
[TBL] [Abstract][Full Text] [Related]
16. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
17. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
[TBL] [Abstract][Full Text] [Related]
19. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
20. Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism.
Andersen BS; Olsen J; Nielsen GL; Steffensen FH; Sørensen HT; Baech J; Gregersen H
Thromb Haemost; 1998 Jan; 79(1):28-31. PubMed ID: 9459317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]